Rasmus Paulin Beske, Laust Emil Roelsgaard Obling, Martin Abild Stengaard Meyer, Jacob Eifer Møller, Jesper Kjaergaard, Pär Ingemar Johansson, Christian Hassager
{"title":"Metabolic effects of high-dose glucocorticoid following out-of-hospital cardiac arrest.","authors":"Rasmus Paulin Beske, Laust Emil Roelsgaard Obling, Martin Abild Stengaard Meyer, Jacob Eifer Møller, Jesper Kjaergaard, Pär Ingemar Johansson, Christian Hassager","doi":"10.1186/s40635-025-00754-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aim: </strong>Patients resuscitated after out-of-hospital cardiac arrest (OHCA) face high morbidity and mortality rates, primarily due to ischemia-reperfusion injury, a complex metabolic disorder that triggers a significant systemic inflammatory response. Glucocorticoids mitigate inflammation but also impact the cells beyond the immune response. This study aims to identify glucocorticoid effects on plasma metabolites.</p><p><strong>Methods: </strong>This explorative sub-study is part of a two-center, blinded, randomized controlled trial (NCT04624776) examining the effects of high-dose glucocorticoid on comatose patients resuscitated from OHCA of presumed cardiac origin. Following resuscitation, patients received 250 mg of methylprednisolone or a placebo in the prehospital setting. Blood samples were collected upon hospital admission and 48 h later. Sixty metabolites were quantified in the plasma using mass spectrometry and compared between groups.</p><p><strong>Results: </strong>In the modified intention-to-treat population, 68 patients received methylprednisolone, and 69 received placebo [median age was 66 years (IQR: 56-74) and 83% were men]. Blood samples were available for 130 patients, 121 (88%) at admission and 117 patients (94% of patients alive) after 48 h. Although a nominal difference was observed at admission, no significant metabolic effects were found after correcting for multiple testing. After 48 h, the placebo group had 83.4% (95% CI 16.9-187.6%) higher prostaglandin E2 and higher levels of linolenic acid and arachidonic acid. The methylprednisolone group had higher levels of tryptophan (47.6%; 95% CI 27.9-70.2%), arginine, and propionylcarnitine (C3).</p><p><strong>Conclusions: </strong>In this exploratory study, early administration of 250 mg of methylprednisolone after resuscitation appeared to drive sustained metabolic effects over 48 h. Specifically, methylprednisolone led to reductions in ω-6 fatty acids and increases in several amino acids, with a notable rise in tryptophan.</p>","PeriodicalId":13750,"journal":{"name":"Intensive Care Medicine Experimental","volume":"13 1","pages":"46"},"PeriodicalIF":2.8000,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12033126/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intensive Care Medicine Experimental","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40635-025-00754-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Background and aim: Patients resuscitated after out-of-hospital cardiac arrest (OHCA) face high morbidity and mortality rates, primarily due to ischemia-reperfusion injury, a complex metabolic disorder that triggers a significant systemic inflammatory response. Glucocorticoids mitigate inflammation but also impact the cells beyond the immune response. This study aims to identify glucocorticoid effects on plasma metabolites.
Methods: This explorative sub-study is part of a two-center, blinded, randomized controlled trial (NCT04624776) examining the effects of high-dose glucocorticoid on comatose patients resuscitated from OHCA of presumed cardiac origin. Following resuscitation, patients received 250 mg of methylprednisolone or a placebo in the prehospital setting. Blood samples were collected upon hospital admission and 48 h later. Sixty metabolites were quantified in the plasma using mass spectrometry and compared between groups.
Results: In the modified intention-to-treat population, 68 patients received methylprednisolone, and 69 received placebo [median age was 66 years (IQR: 56-74) and 83% were men]. Blood samples were available for 130 patients, 121 (88%) at admission and 117 patients (94% of patients alive) after 48 h. Although a nominal difference was observed at admission, no significant metabolic effects were found after correcting for multiple testing. After 48 h, the placebo group had 83.4% (95% CI 16.9-187.6%) higher prostaglandin E2 and higher levels of linolenic acid and arachidonic acid. The methylprednisolone group had higher levels of tryptophan (47.6%; 95% CI 27.9-70.2%), arginine, and propionylcarnitine (C3).
Conclusions: In this exploratory study, early administration of 250 mg of methylprednisolone after resuscitation appeared to drive sustained metabolic effects over 48 h. Specifically, methylprednisolone led to reductions in ω-6 fatty acids and increases in several amino acids, with a notable rise in tryptophan.
背景和目的:院外心脏骤停(OHCA)后复苏的患者面临高发病率和死亡率,主要是由于缺血-再灌注损伤,这是一种复杂的代谢紊乱,可引发显著的全身炎症反应。糖皮质激素可以减轻炎症,但也会影响免疫反应之外的细胞。本研究旨在确定糖皮质激素对血浆代谢物的影响。方法:本探索性亚研究是一项双中心、盲法、随机对照试验(NCT04624776)的一部分,旨在研究高剂量糖皮质激素对心脏源性OHCA昏迷患者复苏的影响。复苏后,患者在院前接受250毫克甲基强的松龙或安慰剂。入院时和48小时后采集血样。用质谱法对血浆中的60种代谢物进行定量分析,并进行组间比较。结果:在修改意向治疗人群中,68名患者接受甲基强的松龙治疗,69名患者接受安慰剂治疗[中位年龄为66岁(IQR: 56-74), 83%为男性]。130例患者的血液样本,入院时121例(88%),48小时后117例(94%的患者存活)。尽管入院时观察到名义上的差异,但校正多次检测后未发现显著的代谢影响。48小时后,安慰剂组前列腺素E2升高83.4% (95% CI 16.9-187.6%),亚麻酸和花生四烯酸水平升高。甲基强的松龙组色氨酸水平较高(47.6%;95% CI 27.9-70.2%),精氨酸和丙基肉碱(C3)。结论:在这项探索性研究中,复苏后早期给予250毫克甲基强的松龙似乎可以在48小时内持续促进代谢作用。具体而言,甲基强的松龙导致ω-6脂肪酸减少,几种氨基酸增加,色氨酸显著增加。